Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS

Ishu Arpan, Rebecca J. Willcocks, Sean C. Forbes, Richard S. Finkel, Donovan J. Lott, William Rooney, William T. Triplett, Claudia R. Senesac, Michael J. Daniels, Barry J. Byrne, Erika Finanger, Barry S. Russman, Dah Jyuu Wang, Gihan I. Tennekoon, Glenn A. Walter, H. L. Sweeney, Krista Vandenborne

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Objective: To evaluate the effects of corticosteroids on the lower extremity muscles in boys with Duchenne muscular dystrophy (DMD) using MRI and magnetic resonance spectroscopy (MRS). Methods: Transverse relaxation time (T2) and fat fraction were measured by MRI/MRS in lower extremity muscles of 15 boys with DMD (age 5.0-6.9 years) taking corticosteroids and 15 corticosteroid-naive boys. Subsequently, fat fraction was measured in a subset of these boys at 1 year. Finally, MRI/MRS data were collected from 16 corticosteroid-naive boys with DMD (age 5-8.9 years) at baseline, 3 months, and 6 months. Five boys were treated with corticosteroids after baseline and the remaining 11 served as corticosteroid-naive controls. Results: Cross-sectional comparisons demonstrated lower muscle T2 and less intramuscular (IM) fat deposition in boys with DMD on corticosteroids, suggesting reduced inflammation/damage and fat infiltration with treatment. Boys on corticosteroids demonstrated less increase in IM fat infiltration at 1 year. Finally, T2 by MRI/MRS detected effects of corticosteroids on leg muscles as early as 3 months after drug initiation. Conclusions: These results demonstrate the ability of MRI/MRS to detect therapeutic effects of corticosteroids in reducing inflammatory processes in skeletal muscles of boys with DMD. Our work highlights the potential of MRI/MRS as a biomarker in evaluating therapeutic interventions in DMD.

Original languageEnglish (US)
Pages (from-to)974-980
Number of pages7
JournalNeurology
Volume83
Issue number11
StatePublished - Sep 1 2014

Fingerprint

Duchenne Muscular Dystrophy
Adrenal Cortex Hormones
Skeletal Muscle
Magnetic Resonance Spectroscopy
Fats
Muscles
Lower Extremity
Boys
Spectroscopy
Therapeutic Uses
Leg
Fat
Biomarkers
Inflammation

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)

Cite this

Arpan, I., Willcocks, R. J., Forbes, S. C., Finkel, R. S., Lott, D. J., Rooney, W., ... Vandenborne, K. (2014). Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology, 83(11), 974-980.

Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. / Arpan, Ishu; Willcocks, Rebecca J.; Forbes, Sean C.; Finkel, Richard S.; Lott, Donovan J.; Rooney, William; Triplett, William T.; Senesac, Claudia R.; Daniels, Michael J.; Byrne, Barry J.; Finanger, Erika; Russman, Barry S.; Wang, Dah Jyuu; Tennekoon, Gihan I.; Walter, Glenn A.; Sweeney, H. L.; Vandenborne, Krista.

In: Neurology, Vol. 83, No. 11, 01.09.2014, p. 974-980.

Research output: Contribution to journalArticle

Arpan, I, Willcocks, RJ, Forbes, SC, Finkel, RS, Lott, DJ, Rooney, W, Triplett, WT, Senesac, CR, Daniels, MJ, Byrne, BJ, Finanger, E, Russman, BS, Wang, DJ, Tennekoon, GI, Walter, GA, Sweeney, HL & Vandenborne, K 2014, 'Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS', Neurology, vol. 83, no. 11, pp. 974-980.
Arpan I, Willcocks RJ, Forbes SC, Finkel RS, Lott DJ, Rooney W et al. Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. Neurology. 2014 Sep 1;83(11):974-980.
Arpan, Ishu ; Willcocks, Rebecca J. ; Forbes, Sean C. ; Finkel, Richard S. ; Lott, Donovan J. ; Rooney, William ; Triplett, William T. ; Senesac, Claudia R. ; Daniels, Michael J. ; Byrne, Barry J. ; Finanger, Erika ; Russman, Barry S. ; Wang, Dah Jyuu ; Tennekoon, Gihan I. ; Walter, Glenn A. ; Sweeney, H. L. ; Vandenborne, Krista. / Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS. In: Neurology. 2014 ; Vol. 83, No. 11. pp. 974-980.
@article{f7787e7a52194586be84f9f6dc4a17f0,
title = "Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS",
abstract = "Objective: To evaluate the effects of corticosteroids on the lower extremity muscles in boys with Duchenne muscular dystrophy (DMD) using MRI and magnetic resonance spectroscopy (MRS). Methods: Transverse relaxation time (T2) and fat fraction were measured by MRI/MRS in lower extremity muscles of 15 boys with DMD (age 5.0-6.9 years) taking corticosteroids and 15 corticosteroid-naive boys. Subsequently, fat fraction was measured in a subset of these boys at 1 year. Finally, MRI/MRS data were collected from 16 corticosteroid-naive boys with DMD (age 5-8.9 years) at baseline, 3 months, and 6 months. Five boys were treated with corticosteroids after baseline and the remaining 11 served as corticosteroid-naive controls. Results: Cross-sectional comparisons demonstrated lower muscle T2 and less intramuscular (IM) fat deposition in boys with DMD on corticosteroids, suggesting reduced inflammation/damage and fat infiltration with treatment. Boys on corticosteroids demonstrated less increase in IM fat infiltration at 1 year. Finally, T2 by MRI/MRS detected effects of corticosteroids on leg muscles as early as 3 months after drug initiation. Conclusions: These results demonstrate the ability of MRI/MRS to detect therapeutic effects of corticosteroids in reducing inflammatory processes in skeletal muscles of boys with DMD. Our work highlights the potential of MRI/MRS as a biomarker in evaluating therapeutic interventions in DMD.",
author = "Ishu Arpan and Willcocks, {Rebecca J.} and Forbes, {Sean C.} and Finkel, {Richard S.} and Lott, {Donovan J.} and William Rooney and Triplett, {William T.} and Senesac, {Claudia R.} and Daniels, {Michael J.} and Byrne, {Barry J.} and Erika Finanger and Russman, {Barry S.} and Wang, {Dah Jyuu} and Tennekoon, {Gihan I.} and Walter, {Glenn A.} and Sweeney, {H. L.} and Krista Vandenborne",
year = "2014",
month = "9",
day = "1",
language = "English (US)",
volume = "83",
pages = "974--980",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS

AU - Arpan, Ishu

AU - Willcocks, Rebecca J.

AU - Forbes, Sean C.

AU - Finkel, Richard S.

AU - Lott, Donovan J.

AU - Rooney, William

AU - Triplett, William T.

AU - Senesac, Claudia R.

AU - Daniels, Michael J.

AU - Byrne, Barry J.

AU - Finanger, Erika

AU - Russman, Barry S.

AU - Wang, Dah Jyuu

AU - Tennekoon, Gihan I.

AU - Walter, Glenn A.

AU - Sweeney, H. L.

AU - Vandenborne, Krista

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Objective: To evaluate the effects of corticosteroids on the lower extremity muscles in boys with Duchenne muscular dystrophy (DMD) using MRI and magnetic resonance spectroscopy (MRS). Methods: Transverse relaxation time (T2) and fat fraction were measured by MRI/MRS in lower extremity muscles of 15 boys with DMD (age 5.0-6.9 years) taking corticosteroids and 15 corticosteroid-naive boys. Subsequently, fat fraction was measured in a subset of these boys at 1 year. Finally, MRI/MRS data were collected from 16 corticosteroid-naive boys with DMD (age 5-8.9 years) at baseline, 3 months, and 6 months. Five boys were treated with corticosteroids after baseline and the remaining 11 served as corticosteroid-naive controls. Results: Cross-sectional comparisons demonstrated lower muscle T2 and less intramuscular (IM) fat deposition in boys with DMD on corticosteroids, suggesting reduced inflammation/damage and fat infiltration with treatment. Boys on corticosteroids demonstrated less increase in IM fat infiltration at 1 year. Finally, T2 by MRI/MRS detected effects of corticosteroids on leg muscles as early as 3 months after drug initiation. Conclusions: These results demonstrate the ability of MRI/MRS to detect therapeutic effects of corticosteroids in reducing inflammatory processes in skeletal muscles of boys with DMD. Our work highlights the potential of MRI/MRS as a biomarker in evaluating therapeutic interventions in DMD.

AB - Objective: To evaluate the effects of corticosteroids on the lower extremity muscles in boys with Duchenne muscular dystrophy (DMD) using MRI and magnetic resonance spectroscopy (MRS). Methods: Transverse relaxation time (T2) and fat fraction were measured by MRI/MRS in lower extremity muscles of 15 boys with DMD (age 5.0-6.9 years) taking corticosteroids and 15 corticosteroid-naive boys. Subsequently, fat fraction was measured in a subset of these boys at 1 year. Finally, MRI/MRS data were collected from 16 corticosteroid-naive boys with DMD (age 5-8.9 years) at baseline, 3 months, and 6 months. Five boys were treated with corticosteroids after baseline and the remaining 11 served as corticosteroid-naive controls. Results: Cross-sectional comparisons demonstrated lower muscle T2 and less intramuscular (IM) fat deposition in boys with DMD on corticosteroids, suggesting reduced inflammation/damage and fat infiltration with treatment. Boys on corticosteroids demonstrated less increase in IM fat infiltration at 1 year. Finally, T2 by MRI/MRS detected effects of corticosteroids on leg muscles as early as 3 months after drug initiation. Conclusions: These results demonstrate the ability of MRI/MRS to detect therapeutic effects of corticosteroids in reducing inflammatory processes in skeletal muscles of boys with DMD. Our work highlights the potential of MRI/MRS as a biomarker in evaluating therapeutic interventions in DMD.

UR - http://www.scopus.com/inward/record.url?scp=84908340223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908340223&partnerID=8YFLogxK

M3 - Article

VL - 83

SP - 974

EP - 980

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 11

ER -